Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Magma (New York, N.Y.)|April 14, 2016
Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical studySophie Schumacher, Florence Pache, Judith Bellmann-Strobl, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2016
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched studyIlya Kister, Tim Spelman, Raed Alroughani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2025
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trialJohn R Corboy, Robert J Fox, Gary Cutter, et al.
Infection Control and Hospital Epidemiology|June 7, 2012
Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usageJames A McKinnell, Danielle F Kunz, Eric Chamot, et al.
International Health|April 7, 2016
Spousal migration and human papillomavirus infection among women in rural western NepalDerek C Johnson, Pema Lhaki, Madhav P Bhatta, et al.
Neurology|September 14, 2019
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosingLana Zhovtis Ryerson, John Foley, Ih Chang, et al.
AIDS (London, England)|June 23, 2006
Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural ChinaHan-Zhu Qian, Sten H Vermund, Richard A Kaslow, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 11, 2020
COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care CenterErica Parrotta, Ilya Kister, Leigh Charvet, et al.
Pageof 14